OPNT logo

Opiant Pharmaceuticals (OPNT) Depreciation And Amortization

Annual D&A

$661.50 K
+$53.00 K+8.71%

December 31, 2021

Summary

Performance

1-Year Change

+8.71%

3-Year Change

+25342.31%

5-Year Change

+31400%

15-Year Change

+31400%

OPNT Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$661.50 K
OPNT annual depreciation & amortization is currently at an all-time high

3-Year Low

$661.50 K
OPNT annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
OPNT previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
OPNT next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$35.57 M
OPNT annual total expenses is $35.57 million

Annual Operating Expenses

$26.50 M
OPNT annual total operating expenses is $26.50 million

Annual Cost Of Goods Sold

$9.07 M
OPNT annual cost of goods sold is $9.07 million

Annual Interest Expense

$2.13 M
OPNT annual interest expense is $2.13 million

Quarterly D&A

$12.00 K
+$3900.00+48.15%

September 30, 2022

Summary

Performance

3-Month Change

+48.15%

1-Year Change

-24.05%

3-Year Change

-52.57%

5-Year Change

+1100%

OPNT Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$582.80 K
OPNT quarterly depreciation & amortization is currently -97.94% below its historical high of $582.80 thousand

3-Year Low

$7900.00
OPNT quarterly depreciation & amortization is currently +51.90% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
OPNT previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
OPNT next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$9.63 M
OPNT quarterly total expenses is $9.63 million

Quarterly Operating Expenses

$9.63 M
OPNT quarterly total operating expenses is $9.63 million

Quarterly Cost Of Goods Sold

-
OPNT quarterly cost of goods sold value is unknown

Quarterly Interest Expense

$390.80 K
OPNT quarterly interest expense is $390.80 thousand

TTM D&A

$610.80 K
-$3800.00-0.62%

September 30, 2022

Summary

Performance

3-Month Change

-0.62%

1-Year Change

+2.62%

3-Year Change

+156.85%

5-Year Change

+156.85%

OPNT TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$661.60 K
OPNT TTM depreciation & amortization is currently -7.68% below its historical high of $661.60 thousand

3-Year Low

$610.80 K
OPNT TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
OPNT previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
OPNT next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$35.57 M
OPNT annual total expenses is $35.57 million

Annual Operating Expenses

$26.50 M
OPNT annual total operating expenses is $26.50 million

TTM Cost Of Goods Sold

-
OPNT TTM cost of goods sold value is unknown

TTM Interest Expense

$1.72 M
OPNT TTM interest expense is $1.72 million

OPNT Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.7%-24.1%+2.6%
3 y3 years+10000.0%-52.6%+156.8%
5 y5 years+10000.0%+1100.0%+156.8%

OPNT Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-97.9%-34.2%-7.7%at low
5 y5-yearat high-64.1%-97.9%-34.2%-7.7%-61.1%
alltimeall timeat high-100.0%-97.9%-100.0%-7.7%-100.0%

Opiant Pharmaceuticals Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2022
-
$12.00 K(+48.1%)
$610.80 K(-0.6%)
Jun 2022
-
$8100.00(+2.5%)
$614.60 K(-3.7%)
Mar 2022
-
$7900.00(-98.6%)
$638.00 K(-3.6%)
Dec 2021
$661.50 K(+8.7%)
$582.80 K(+3588.6%)
$661.60 K(+11.2%)
Sep 2021
-
$15.80 K(-49.8%)
$595.20 K(-2.6%)
Jun 2021
-
$31.50 K(0.0%)
$611.00 K(+1.4%)
Mar 2021
-
$31.50 K(-93.9%)
$602.70 K(-1.0%)
Dec 2020
$608.50 K(+155.9%)
$516.40 K(+1534.2%)
$608.50 K(+102.8%)
Sep 2020
-
$31.60 K(+36.2%)
$300.00 K(+2.1%)
Jun 2020
-
$23.20 K(-37.8%)
$293.70 K(+6.9%)
Mar 2020
-
$37.30 K(-82.1%)
$274.80 K(+15.6%)
Dec 2019
$237.80 K(+9046.2%)
$207.90 K(+721.7%)
$237.80 K(+679.7%)
Sep 2019
-
$25.30 K(+488.4%)
$30.50 K(+486.5%)
Jun 2019
-
$4300.00(+1333.3%)
$5200.00(+173.7%)
Mar 2019
-
$300.00(-50.0%)
$1900.00(-26.9%)
Dec 2018
$2600.00(+23.8%)
$600.00(>+9900.0%)
$2600.00(+30.0%)
Sep 2018
-
$0.00(-100.0%)
$2000.00(-33.3%)
Jun 2018
-
$1000.00(0.0%)
$3000.00(-9.1%)
Mar 2018
-
$1000.00(0.0%)
$3300.00(-36.5%)
Dec 2017
$2100.00(-58.8%)
-
-
Oct 2017
-
$1000.00(-23.1%)
$5200.00(0.0%)
Jul 2017
$5100.00(+112.5%)
$1300.00(0.0%)
$5200.00(+2.0%)
Apr 2017
-
$1300.00(-18.8%)
$5100.00(+18.6%)
Jan 2017
-
$1600.00(+60.0%)
$4300.00(+43.3%)
Oct 2016
-
$1000.00(-16.7%)
$3000.00(+30.4%)
Jul 2016
$2400.00
$1200.00(+140.0%)
$2300.00(+64.3%)
Apr 2016
-
$500.00(+66.7%)
$1400.00(+16.7%)
DateAnnualQuarterlyTTM
Jan 2016
-
$300.00(0.0%)
$1200.00(0.0%)
Oct 2015
-
$300.00(0.0%)
$1200.00(0.0%)
Jul 2015
$1400.00(0.0%)
$300.00(0.0%)
$1200.00(-7.7%)
Apr 2015
-
$300.00(0.0%)
$1300.00(0.0%)
Jan 2015
-
$300.00(0.0%)
$1300.00(0.0%)
Oct 2014
-
$300.00(-25.0%)
$1300.00(-7.1%)
Jul 2014
$1400.00(0.0%)
$400.00(+33.3%)
$1400.00(+7.7%)
Apr 2014
-
$300.00(0.0%)
$1300.00(0.0%)
Jan 2014
-
$300.00(-25.0%)
$1300.00(0.0%)
Oct 2013
-
$400.00(+33.3%)
$1300.00(+8.3%)
Jul 2013
$1400.00(0.0%)
$300.00(0.0%)
$1200.00(-20.0%)
Apr 2013
-
$300.00(0.0%)
$1500.00(0.0%)
Jan 2013
-
$300.00(0.0%)
$1500.00(0.0%)
Oct 2012
-
$300.00(-50.0%)
$1500.00(0.0%)
Jul 2012
$1400.00(+40.0%)
$600.00(+100.0%)
$1500.00(+25.0%)
Apr 2012
-
$300.00(0.0%)
$1200.00(0.0%)
Jan 2012
-
$300.00(0.0%)
$1200.00(0.0%)
Oct 2011
-
$300.00(0.0%)
$1200.00(0.0%)
Jul 2011
$1000.00(+100.0%)
$300.00(0.0%)
$1200.00(0.0%)
Apr 2011
-
$300.00(0.0%)
$1200.00(0.0%)
Jan 2011
-
$300.00(0.0%)
$1200.00(+33.3%)
Oct 2010
-
$300.00(0.0%)
$900.00(+50.0%)
Jul 2010
$500.00(>+9900.0%)
$300.00(0.0%)
$600.00(+100.0%)
Apr 2010
-
$300.00(>+9900.0%)
$300.00(>+9900.0%)
Jan 2010
-
$0.00(0.0%)
$0.00(0.0%)
Oct 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jul 2009
$0.00
$0.00(0.0%)
$0.00(0.0%)
Apr 2009
-
$0.00
$0.00

FAQ

  • What is Opiant Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals annual D&A year-on-year change?
  • What is Opiant Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals quarterly D&A year-on-year change?
  • What is Opiant Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for Opiant Pharmaceuticals?
  • What is Opiant Pharmaceuticals TTM D&A year-on-year change?

What is Opiant Pharmaceuticals annual depreciation & amortization?

The current annual D&A of OPNT is $661.50 K

What is the all time high annual D&A for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high annual depreciation & amortization is $661.50 K

What is Opiant Pharmaceuticals annual D&A year-on-year change?

Over the past year, OPNT annual depreciation & amortization has changed by +$53.00 K (+8.71%)

What is Opiant Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of OPNT is $12.00 K

What is the all time high quarterly D&A for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high quarterly depreciation & amortization is $582.80 K

What is Opiant Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, OPNT quarterly depreciation & amortization has changed by -$3800.00 (-24.05%)

What is Opiant Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of OPNT is $610.80 K

What is the all time high TTM D&A for Opiant Pharmaceuticals?

Opiant Pharmaceuticals all-time high TTM depreciation & amortization is $661.60 K

What is Opiant Pharmaceuticals TTM D&A year-on-year change?

Over the past year, OPNT TTM depreciation & amortization has changed by +$15.60 K (+2.62%)